Regulus Therapeutics Inc. Gains 35.56%
Wed, Mar 02, 2022 at 05:30 PM
Regulus Therapeutics Inc. (RGLS:NASDAQ) soared at $0.31, representing a gain of 35.6%. The stock appeared on our News Catalysts scanner on Thu, Feb 24, 2022 at 10:32 AM in the 'BIOTECH' category. From Tue, Feb 15, 2022, the stock recorded 22.22% Up Days and 30.00% Green Days
About Regulus Therapeutics Inc. (RGLS:NASDAQ)
Regulus Therapeutics Inc is a biotechnology company that focuses on the development of microRNA therapies. MicroRNA is a noncoding ribonucleic acid that regulates most genes in the genome.
Top 10 Gainers:
- ECMOHO Limited (MOHO:NASDAQ), 56.65%
- Imperial Petroleum Inc. (IMPP:NASDAQ), 39.19%
- Nordstrom, Inc. (JWN:NYSE), 37.82%
- Regulus Therapeutics Inc. (RGLS:NASDAQ), 35.56%
- Indonesia Energy Corporation Limited (INDO:NYSEMKT), 34.51%
- Trevi Therapeutics, Inc. (TRVI:NASDAQ), 32.02%
- Arlo Technologies, Inc. (ARLO:NYSE), 28.92%
- Rocky Brands, Inc. (RCKY:NASDAQ), 26.59%
- China SXT Pharmaceuticals, Inc. (SXTC:NASDAQ), 26.07%
- Universal Security Instruments, Inc. (UUU:NYSEMKT), 25.89%